Company intelligence / Profile preview

Fidelity BioPharma

New Haven, Connecticut, United Statesfbpus.com ↗

Ownership: Private
Development stage: Other

Overview

Fidelity BioPharma develops and delivers healthcare products globally, stays current with drug trends and technology, and supports clinical trials for other developers. The company emphasizes safety in testing, manufacturing, and product transfer. No specific clinical results or pipeline programs are disclosed publicly as of 2025

Industry: Contract Research Organization

Partnerships

Other drug developers collaborate with the company for clinical trial support

Beyond the preview

Go deeper on Fidelity BioPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fidelity BioPharma.

Explore the full profile